Uncovering Institutional Buying In Adma Biologics Inc (NASDAQ: ADMA)
BlackRock Fund Advisors recently announced the acquisition of new stake in Adma Biologics Inc (NASDAQ:ADMA). The institutional investor has increased its shareholding in the Healthcare company by 1.87% to 15.09 million shares with purchase of 0.28 million shares. This fresh investment now brings its stake to 6.68% valued currently at $55.84 million. In addition, The […]
Adma Biologics Inc (NASDAQ: ADMA): Reassessing Prospects
Adma Biologics Inc (ADMA) concluded trading on 12/28/23 at a closing price of $4.52, with 4.18 million shares of worth about $18.9 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 24.52% during that period and on Thursday the price saw a gain of […]
